Examkin

Soru

Zorluk: ZorPreventive Care and Screening

A 54-year-old woman comes to the clinic for a routine health maintenance visit. She has no current symptoms and feels well. Her surgical history is significant for a total abdominal hysterectomy (removal of the uterus and cervix) with bilateral salpingo-oophorectomy performed 4 years ago for symptomatic, heavy uterine bleeding caused by leiomyomas. Surgical pathology at that time confirmed benign leiomyomas. A detailed review of her past gynecologic history reveals that she had an abnormal Papanicolaou (Pap) test 12 years ago, which led to a diagnosis of cervical intraepithelial neoplasia (CIN) grade 3. She was treated with a loop electrosurgical excision procedure (LEEP) with clear margins. Subsequent Pap tests prior to her hysterectomy were normal. She has not had any screening tests since her hysterectomy. Vital signs are within normal limits, and physical examination of the vaginal vault is unremarkable. Which of the following is the most appropriate next step in the preventive care of this patient?

  1. A
    Discontinue all future lower genital tract screening.
  2. Perform vaginal cuff cytology and human papillomavirus (HPV) cotesting.Cevap
  3. C
    Advise the patient to return for screening at age 65.
  4. D
    Order a serum assay for human papillomavirus (HPV) antibodies.
  5. E
    Perform a screening transvaginal ultrasound.

Cevap

The correct answer is to perform vaginal cuff cytology and human papillomavirus (HPV) cotesting.
The correct action is to perform vaginal cuff cytology and human papillomavirus (HPV) cotesting. According to the US Preventive Services Task Force (USPSTF) and the American College of Obstetricians and Gynecologists (ACOG), women who have undergone a total hysterectomy (removal of the uterus and cervix) for benign indications should stop routine cervical cancer screening. However, a major exception exists: women with a history of high-grade precancerous cervical lesions (such as CIN 2 or CIN 3) or cervical cancer must continue routine screening for a total of 20 years after the initial treatment of the high-grade lesion, regardless of the hysterectomy and even if it extends screening past the age of 65. Because this patient was treated for CIN 3 12 years ago, she is still within the 20-year surveillance window and requires ongoing screening of the vaginal cuff.

Adım Adım Çözüm

1
Evaluate the impact of the patient's surgical history on screening requirements.
The patient had a total hysterectomy (cervix removed) for benign leiomyomas. Normally, this permits the cessation of cervical cancer screening.
Routine cervical cancer screening is not recommended for individuals without a cervix unless they have specific high-risk historical factors.
2
Assess the patient's past gynecologic history for exceptions to the standard hysterectomy rule.
The patient has a documented history of cervical intraepithelial neoplasia (CIN) grade 3 treated 12 years ago.
A history of high-grade dysplasia (CIN 2 or 3) or cervical cancer is a critical exception that modifies standard screening cessation protocols.
3
Apply the appropriate guideline for a patient with a history of CIN 3 who subsequently underwent a hysterectomy.
The patient must undergo vaginal cuff screening (via cytology or cotesting) for a total of 20 years post-treatment.
Current guidelines mandate 20 years of continuous surveillance after treatment for CIN 2/3. Because her treatment was 12 years ago, she requires 8 more years of screening, making testing indicated at this visit.

Anahtar Kavram

Women with a history of CIN 2, CIN 3, or cervical cancer must continue age-based screening for a total of 20 years after treatment, which involves vaginal cuff screening if a total hysterectomy is performed.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru